Mechanisms of antihypertensive action of beta-adrenergic blocking drugs: Evidence against potentiation of baroreflexes

G. Parati, G. Pomidossi, G. Grassi, C. Gavazzi, A. Ramirez, L. Gregorini, G. Mancia

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

A possibility that can be advanced to explain the antihypertensive effect of beta-blocking drugs is that they act through the baroreflex control of the cardiovascular system. In 38 essential hypertensive patients we measured: (1) The lengthening and shortening in R-R interval caused by stimulation or deactivation of arterial baroreceptors (vasoactive drug technique); (2) The fall and rise in blood pressure caused by stimulation and deactivation of carotid baroreceptors (neck chamber); (3) The rise in forearm vascular resistance caused by deactivation of cardiopulmonary receptors (lower body suction). The study was made before and after 6-10 days' administration of nadolol (80-360 mg once a day) or acebutolol (200-600 mg t.i.d.). Nadolol and acebutolol similarly reduced blood pressure and heart rate. Either drug increased heart rate responses to arterial baroreceptor manipulation but the increase fell short of statistical significance. Blood pressure and vasomotor responses to carotid baroreceptor and cardiopulmonary receptor manipulation were also not significantly modified by beta blockade. The baroreceptor control of heart rate and blood pressure showed a modification, however, insofar as a resetting towards the lower blood pressure values occurred. These findings demonstrate that arterial baroreceptor and cardiopulmonary receptor control of circulation is not potentiated by beta-blocking drugs, and that therefore this mechanism cannot account for their antihypertensive effect. The resetting of the baroreflex that occurs during beta blockade may, however, contribute to maintain the hypotension obtained.

Original languageEnglish
Pages (from-to)19-25
Number of pages7
JournalEuropean Heart Journal
Volume4
Issue numberSuppl. D
Publication statusPublished - 1983

Fingerprint

Pressoreceptors
Baroreflex
Adrenergic Agents
Antihypertensive Agents
Blood Pressure
Nadolol
Acebutolol
Heart Rate
Pharmaceutical Preparations
Suction
Cardiovascular System
Forearm
Vascular Resistance
Hypotension
Neck

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Mechanisms of antihypertensive action of beta-adrenergic blocking drugs : Evidence against potentiation of baroreflexes. / Parati, G.; Pomidossi, G.; Grassi, G.; Gavazzi, C.; Ramirez, A.; Gregorini, L.; Mancia, G.

In: European Heart Journal, Vol. 4, No. Suppl. D, 1983, p. 19-25.

Research output: Contribution to journalArticle

Parati, G, Pomidossi, G, Grassi, G, Gavazzi, C, Ramirez, A, Gregorini, L & Mancia, G 1983, 'Mechanisms of antihypertensive action of beta-adrenergic blocking drugs: Evidence against potentiation of baroreflexes', European Heart Journal, vol. 4, no. Suppl. D, pp. 19-25.
Parati, G. ; Pomidossi, G. ; Grassi, G. ; Gavazzi, C. ; Ramirez, A. ; Gregorini, L. ; Mancia, G. / Mechanisms of antihypertensive action of beta-adrenergic blocking drugs : Evidence against potentiation of baroreflexes. In: European Heart Journal. 1983 ; Vol. 4, No. Suppl. D. pp. 19-25.
@article{3950374034414ea8b733378affda02b8,
title = "Mechanisms of antihypertensive action of beta-adrenergic blocking drugs: Evidence against potentiation of baroreflexes",
abstract = "A possibility that can be advanced to explain the antihypertensive effect of beta-blocking drugs is that they act through the baroreflex control of the cardiovascular system. In 38 essential hypertensive patients we measured: (1) The lengthening and shortening in R-R interval caused by stimulation or deactivation of arterial baroreceptors (vasoactive drug technique); (2) The fall and rise in blood pressure caused by stimulation and deactivation of carotid baroreceptors (neck chamber); (3) The rise in forearm vascular resistance caused by deactivation of cardiopulmonary receptors (lower body suction). The study was made before and after 6-10 days' administration of nadolol (80-360 mg once a day) or acebutolol (200-600 mg t.i.d.). Nadolol and acebutolol similarly reduced blood pressure and heart rate. Either drug increased heart rate responses to arterial baroreceptor manipulation but the increase fell short of statistical significance. Blood pressure and vasomotor responses to carotid baroreceptor and cardiopulmonary receptor manipulation were also not significantly modified by beta blockade. The baroreceptor control of heart rate and blood pressure showed a modification, however, insofar as a resetting towards the lower blood pressure values occurred. These findings demonstrate that arterial baroreceptor and cardiopulmonary receptor control of circulation is not potentiated by beta-blocking drugs, and that therefore this mechanism cannot account for their antihypertensive effect. The resetting of the baroreflex that occurs during beta blockade may, however, contribute to maintain the hypotension obtained.",
author = "G. Parati and G. Pomidossi and G. Grassi and C. Gavazzi and A. Ramirez and L. Gregorini and G. Mancia",
year = "1983",
language = "English",
volume = "4",
pages = "19--25",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "Suppl. D",

}

TY - JOUR

T1 - Mechanisms of antihypertensive action of beta-adrenergic blocking drugs

T2 - Evidence against potentiation of baroreflexes

AU - Parati, G.

AU - Pomidossi, G.

AU - Grassi, G.

AU - Gavazzi, C.

AU - Ramirez, A.

AU - Gregorini, L.

AU - Mancia, G.

PY - 1983

Y1 - 1983

N2 - A possibility that can be advanced to explain the antihypertensive effect of beta-blocking drugs is that they act through the baroreflex control of the cardiovascular system. In 38 essential hypertensive patients we measured: (1) The lengthening and shortening in R-R interval caused by stimulation or deactivation of arterial baroreceptors (vasoactive drug technique); (2) The fall and rise in blood pressure caused by stimulation and deactivation of carotid baroreceptors (neck chamber); (3) The rise in forearm vascular resistance caused by deactivation of cardiopulmonary receptors (lower body suction). The study was made before and after 6-10 days' administration of nadolol (80-360 mg once a day) or acebutolol (200-600 mg t.i.d.). Nadolol and acebutolol similarly reduced blood pressure and heart rate. Either drug increased heart rate responses to arterial baroreceptor manipulation but the increase fell short of statistical significance. Blood pressure and vasomotor responses to carotid baroreceptor and cardiopulmonary receptor manipulation were also not significantly modified by beta blockade. The baroreceptor control of heart rate and blood pressure showed a modification, however, insofar as a resetting towards the lower blood pressure values occurred. These findings demonstrate that arterial baroreceptor and cardiopulmonary receptor control of circulation is not potentiated by beta-blocking drugs, and that therefore this mechanism cannot account for their antihypertensive effect. The resetting of the baroreflex that occurs during beta blockade may, however, contribute to maintain the hypotension obtained.

AB - A possibility that can be advanced to explain the antihypertensive effect of beta-blocking drugs is that they act through the baroreflex control of the cardiovascular system. In 38 essential hypertensive patients we measured: (1) The lengthening and shortening in R-R interval caused by stimulation or deactivation of arterial baroreceptors (vasoactive drug technique); (2) The fall and rise in blood pressure caused by stimulation and deactivation of carotid baroreceptors (neck chamber); (3) The rise in forearm vascular resistance caused by deactivation of cardiopulmonary receptors (lower body suction). The study was made before and after 6-10 days' administration of nadolol (80-360 mg once a day) or acebutolol (200-600 mg t.i.d.). Nadolol and acebutolol similarly reduced blood pressure and heart rate. Either drug increased heart rate responses to arterial baroreceptor manipulation but the increase fell short of statistical significance. Blood pressure and vasomotor responses to carotid baroreceptor and cardiopulmonary receptor manipulation were also not significantly modified by beta blockade. The baroreceptor control of heart rate and blood pressure showed a modification, however, insofar as a resetting towards the lower blood pressure values occurred. These findings demonstrate that arterial baroreceptor and cardiopulmonary receptor control of circulation is not potentiated by beta-blocking drugs, and that therefore this mechanism cannot account for their antihypertensive effect. The resetting of the baroreflex that occurs during beta blockade may, however, contribute to maintain the hypotension obtained.

UR - http://www.scopus.com/inward/record.url?scp=0020557062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020557062&partnerID=8YFLogxK

M3 - Article

C2 - 6137380

AN - SCOPUS:0020557062

VL - 4

SP - 19

EP - 25

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - Suppl. D

ER -